Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1286) 1286
life sciences & biomedicine (1277) 1277
neutrophil-to-lymphocyte ratio (1059) 1059
lymphocytes (780) 780
humans (724) 724
neutrophils (648) 648
female (642) 642
prognosis (630) 630
male (608) 608
middle aged (565) 565
neutrophil to lymphocyte ratio (544) 544
aged (453) 453
oncology (414) 414
adult (392) 392
retrospective studies (384) 384
inflammation (381) 381
analysis (290) 290
lymphocyte count (278) 278
surgery (222) 222
platelet-to-lymphocyte ratio (221) 221
leukocyte count (213) 213
medical prognosis (211) 211
fungi (208) 208
aged, 80 and over (191) 191
care and treatment (190) 190
cancer (187) 187
patients (185) 185
mortality (181) 181
lymphocytes - pathology (178) 178
medical research (177) 177
medicine, experimental (173) 173
neutrophils - pathology (172) 172
biomarkers (165) 165
risk factors (164) 164
multivariate analysis (160) 160
general & internal medicine (151) 151
predictive value of tests (149) 149
research (148) 148
medicine, general & internal (144) 144
metastasis (143) 143
health aspects (142) 142
chemotherapy (130) 130
blood (127) 127
neutrophil‐to‐lymphocyte ratio (125) 125
disease-free survival (124) 124
platelet to lymphocyte ratio (123) 123
original (121) 121
roc curve (119) 119
blood platelets (117) 117
biomarkers - blood (113) 113
research article (111) 111
tumors (108) 108
medicine & public health (107) 107
c-reactive protein (106) 106
cardiovascular system & cardiology (106) 106
patient outcomes (105) 105
young adult (105) 105
survival (103) 103
development and progression (102) 102
neutrophils - cytology (100) 100
original article (98) 98
studies (96) 96
treatment outcome (96) 96
mean platelet volume (93) 93
platelet count (90) 90
original research (88) 88
neoplasm staging (87) 87
kaplan-meier estimate (86) 86
medicine (86) 86
blood cell count (85) 85
diagnosis (83) 83
hematology (83) 83
proportional hazards models (83) 83
neoplasms. tumors. oncology. including cancer and carcinogens (79) 79
survival analysis (79) 79
cancer therapies (76) 76
lymphocytes - cytology (75) 75
medicine, research & experimental (75) 75
research & experimental medicine (75) 75
severity of illness index (75) 75
follow-up studies (74) 74
gastroenterology & hepatology (74) 74
meta-analysis (74) 74
neurosciences & neurology (74) 74
neutrophils - metabolism (74) 74
survival rate (71) 71
age (70) 70
overall survival (68) 68
abridged index medicus (67) 67
colorectal cancer (66) 66
biomarker (65) 65
hepatocellular carcinoma (65) 65
case-control studies (61) 61
lymphocytes - metabolism (60) 60
medical laboratory technology (60) 60
regression analysis (60) 60
lung cancer (59) 59
urology & nephrology (59) 59
hospitals (58) 58
peripheral vascular disease (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1723) 1723
Turkish (23) 23
Korean (15) 15
Portuguese (15) 15
German (7) 7
Spanish (7) 7
Chinese (6) 6
Japanese (6) 6
Persian (2) 2
Indonesian (1) 1
Italian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: A systematic review and meta-analysis
by Bowen, Randy C and Little, Nancy Ann B and Harmer, Joshua R and Ma, Junjie and Mirabelli, Luke G and Roller, Kyle D and Breivik, Andrew Mackay and Signor, Emily and Miller, Alec B and Khong, Hung T
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 19, pp. 32171 - 32189
Biomarkers | Gastrointestinal cancers | Overall survival | Neutrophil-to-lymphocyte ratio | Prognostic indicator | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Prognosis | Gastrointestinal Neoplasms - blood | Gastrointestinal Neoplasms - mortality | Lymphocytes | Humans | Neutrophils | Proportional Hazards Models | Survival Analysis | Lymphocyte Count | Publication Bias | Leukocyte Count | Gastrointestinal Neoplasms - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
by Solmaz Medeni, Serife and Acar, Celal and Olgun, Aybuke and Acar, Alev and Seyhanlı, Ahmet and Taskıran, Emin and Sevindik, Omur Gokmen and Alacacıoglu, Inci and Piskin, Ozden and Ozcan, Mehmet Ali and Demirkan, Fatih and Undar, Bulent and Ozsan, Guner Hayri
Clinical transplantation, ISSN 0902-0063, 09/2018, Volume 32, Issue 9, pp. e13359 - n/a
Monocyte Lymphocyte Ratio (MLR) | Neutrophil‐to‐Lymphocyte Ratio (NLR) | Multiple myeloma | Platelet‐to‐Lymphocyte Ratio (PLR) | Neutrophil-to-Lymphocyte Ratio (NLR) | Platelet-to-Lymphocyte Ratio (PLR) | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Autografts | Medical research | Prognosis | Lymphocytes | Analysis | Stem cells | Medicine, Experimental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
by Diem, Stefan and Schmid, Sabine and Krapf, Mirjam and Flatz, Lukas and Born, Diana and Jochum, Wolfram and Templeton, Arnoud J and Früh, Martin
Lung cancer (Amsterdam, Netherlands), ISSN 0169-5002, 09/2017, Volume 111, pp. 176 - 181
Neutrophil-to-Lymphocyte ratio | Overall survival | Non small cell lung cancer | Platelet-to-Lymphocyte ratio | Immunotherapy | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Molecular Targeted Therapy | Neoplasm Metastasis | Aged, 80 and over | Female | Leukocyte Count | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Neutrophils | Carcinoma, Non-Small-Cell Lung - mortality | Platelet Count | Antineoplastic Agents, Immunological - therapeutic use | Survival Analysis | Biomarkers | Lymphocyte Count | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Lymphocytes | Analysis | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
by Russo, Alessandro and Franchina, Tindara and Ricciardi, Giuseppina R.R and Battaglia, Alessandra and Scimone, Antonino and Berenato, Rosa and Giordano, Antonio and Adamo, Vincenzo
Journal of cellular physiology, ISSN 0021-9541, 10/2018, Volume 233, Issue 10, pp. 6337 - 6343
platelet‐to‐lymphocyte ratio | neutrophil‐to‐lymphocyte ratio | NSCLC | biomarker | Nivolumab | platelet-to-lymphocyte ratio | neutrophil-to-lymphocyte ratio | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Blood Platelets - pathology | Carcinoma, Non-Small-Cell Lung - pathology | Drug-Related Side Effects and Adverse Reactions - blood | Inflammation - pathology | Prognosis | Docetaxel - adverse effects | Humans | Middle Aged | Male | Treatment Outcome | Nivolumab - adverse effects | Inflammation - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Biomarkers, Tumor - blood | Docetaxel - administration & dosage | Lymphocytes - pathology | Inflammation - drug therapy | Adult | Carcinoma, Non-Small-Cell Lung - blood | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neutrophils - pathology | Nivolumab - administration & dosage | Correlation | Immunotherapy | Lung cancer | Neutrophilia | Biomarkers | Non-small cell lung carcinoma | Thrombocytosis | Bioindicators | Inflammation | Patients | Indicators | Cancer | Index Medicus | Rapid Communications | Rapid Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Significance of neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma
by Goh, Brian K.P and Kam, Juinn Huar and Lee, Ser‐Yee and Chan, Chung‐Yip and Allen, John C and Jeyaraj, Premaraj and Cheow, Peng‐Chung and Chow, Pierce K.H and Ooi, London L.P.J and Chung, Alexander Y.F
Journal of surgical oncology, ISSN 0022-4790, 05/2016, Volume 113, Issue 6, pp. 621 - 627
platelet‐to‐lymphocyte ratio | huge | neutrophil‐to‐lymphocyte ratio | prognostic nutrition index | hepatocellular carcinoma | platelet-to-lymphocyte ratio | neutrophil-to-lymphocyte ratio | Oncology | Life Sciences & Biomedicine | Surgery | Science & Technology | Carcinoma, Hepatocellular - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Hepatectomy - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - etiology | Nutrition Assessment | Liver Neoplasms - blood | Adult | Female | Liver Neoplasms - pathology | Leukocyte Count | Nutritional Status | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neoplasm Recurrence, Local - blood | Neutrophils - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Hospital Mortality | Risk Factors | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Tumor Burden | Platelet Count | Blood Platelets - metabolism | Carcinoma, Hepatocellular - pathology | Survival Analysis | ROC Curve | Aged | Lymphocytes | Mortality | Neutrophils | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prognostic role of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review and meta‐analysis
by Li, Mu‐Xing and Liu, Xue‐Min and Zhang, Xu‐Feng and Zhang, Jian‐Fei and Wang, Wan‐Li and Zhu, Ying and Dong, Jian and Cheng, Ji‐Wen and Liu, Zheng‐Wen and Ma, Le and Lv, Yi
International journal of cancer, ISSN 0020-7136, 05/2014, Volume 134, Issue 10, pp. 2403 - 2413
colorectal cancer | neutrophil‐to‐lymphocyte ratio | meta‐analysis | prognosis | meta-analysis | neutrophil-to-lymphocyte ratio | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Disease-Free Survival | Colorectal Neoplasms - therapy | Lymphocytes - pathology | Prognosis | Humans | Lymphocyte Count | Colorectal Neoplasms - pathology | Neoplasm Staging | Colorectal Neoplasms - metabolism | Carcinoembryonic Antigen - metabolism | Neutrophils - pathology | Lymphocytes | Analysis | Colorectal cancer | Leucocytes | Systematic review | Meta-analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus
by Wu, Yunxiu and Chen, Yanjuan and Yang, Xianming and Chen, Lishu and Yang, Yihua
International immunopharmacology, ISSN 1567-5769, 07/2016, Volume 36, pp. 94 - 99
Platelet-to-lymphocyte ratio | Systemic lupus erythematosus | Disease activity | Neutrophil-to-lymphocyte ratio | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | Blood Platelets - immunology | Complement C4 - metabolism | Complement C3 - metabolism | Cell Count | Humans | Middle Aged | Neutrophils - immunology | Child, Preschool | Male | Disease Progression | Lupus Erythematosus, Systemic - diagnosis | Young Adult | C-Reactive Protein - metabolism | Lymphocytes - immunology | Nephritis - immunology | Adolescent | Lupus Erythematosus, Systemic - immunology | Adult | Female | Aged | Nephritis - diagnosis | Child | Lupus | Care and treatment | Lymphocytes | Medicine, Experimental | Medical research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma: A Retrospective Analysis
by Mano, Yohei and Shirabe, Ken and Yamashita, Yo-ichi and Harimoto, Norifumi and Tsujita, Eiji and Takeishi, Kazuki and Aishima, Shinichi and Ikegami, Toru and Yoshizumi, Tomoharu and Yamanaka, Takeharu and Maehara, Yoshihiko
Annals of surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 301 - 305
liver resection | tumor-associated macrophage | prognosis | hepatocellular carcinoma | blood neutrophil-to-lymphocyte ratio | Life Sciences & Biomedicine | Surgery | Science & Technology | Lymphocytes - metabolism | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Biomarkers - blood | Liver Neoplasms - mortality | Hepatectomy | Liver Neoplasms - blood | Survival Analysis | Female | ROC Curve | Aged | Leukocyte Count | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neutrophils - metabolism | Preoperative Period | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights